OR WAIT null SECS
November 02, 2022
Johnson & Johnson’s acquisition of Abiomed, a provider of heart pump technologies, is designed to bolster their position in the medical technology sector.
Lonza and Singzyme will use Singzyme’s enzymatic conjugation platform to develop novel bioconjugates.
November 01, 2022
Purolite and Repligen have extended their existing ligand partnership through 2032.
FDA has accepted Ashland’s Viatel bioresorbable mPEG-PDLLA pharmaceutical excipient into the FDA Novel Excipient Review Pilot Program.
October 26, 2022
AstraZeneca’s Imjudo (tremelimumab) was approved by FDA in combination with Imfinzi (durvalumab) for treating unresectable liver cancer.
South Africa’s vaccine regulator has reached new WHO level to ensure safety, quality, and effectiveness.
October 25, 2022
Under the new collaboration with Tempus, GSK will have access to de-identified patient data to accelerate drug discovery, improve clinical trial design, and speed up enrollment.
October 21, 2022
Aragen’s new 12,000 ft² facility will include various dosage form capabilities, including oral solids, liquids, topicals, and films.
Recipharm’s new high speed filling line, designed for pre-filled syringes and cartridges, is expected to be operational by May 2023.
Aenova Group and Microcaps are partnering to enable new customized formulations for product development and life cycle management solutions.